India to Russia: Levofloxacin Export Trade Route

The India to Russia Levofloxacin corridor is one of India's established pharmaceutical export routes, with 81 shipments documented worth a combined $5.8M USD. The route is dominated by SENTISS PHARMA PRIVATE LIMITED, which alone accounts for roughly 69% of all export value, reflecting the consolidated nature of India's levofloxacin manufacturing sector.

Across 11 active suppliers, the average shipment value stands at $71.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with levofloxacin's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 10.0%, placing it at rank #3 among India's top levofloxacin export destinations globally.

On the import side, key buyers of Indian levofloxacin in Russia include LLC SENTISS RUS, LLC ?SENTISS RUS?, LLC ?Sentiss Rus? and 15 others. LLC SENTISS RUS is the single largest importer with 27 shipments valued at $3.0M USD.

India's levofloxacin exports to Russia are driven primarily by a handful of large-scale manufacturers. SENTISS PHARMA PRIVATE LIMITED with 54 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Russia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SENTISS PHARMA PRIVATE LIMITED, SIMPEX PHARMA PRIVATE LIMITED, HIGLANCE LABORATORIES PRIVATE LIMITED — together account for 81% of total trade value on this route. The average shipment value of $71.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as signicef eye drops0.5%(vial-dropper plastic)5 ml no.1 bar#8901236020065 salt#levofloxacin b/n:n24125 md:05/24 ed:05/27 and signicef eye drops0.5%vial-dropper plastic5ml no.1bar#8901236020065salt#levofloxacin b/n: n23329 md:10/23 ed:10/26, suggesting that buyers in Russia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, LLC SENTISS RUS is the largest importer with 27 shipments worth $3.0M USD — representing 52% of all levofloxacin imports from India on this route. A total of 18 buyers are active on this corridor.